ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC advisors OK New Grant Programs In Tobacco, Rural Area

November 12, 1993

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

White House Says Upton Appointment Due In Two Weeks

July 29, 1977

UNC Lineberger Center Recruits Richard Goldberg From Mayo

April 11, 2003

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013